HopeStage
Back to all studies
CompletedNCT00246207

Methylphenidate treatment for adults with ADHD

About this titleRead the official source — NCT00246207
Medication studyAges 18–65
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2005
Recruitment status
Completed
Enrollment listed in the registry
32
Sponsor
Janssen-Ortho Inc., Canada
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Not clearly listed
Age range
From 18 Years to 65 Years
Official registry ID
NCT00246207
Official title
Show the full official title

An Open-label Study Evaluating the Safety and Effectiveness of OROS Methylphenidate Hydrochloride (CONCERTA) in Adults With Attention Deficit Hyperactivity Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Ortho Inc., Canada.

Did this study involve medication?

Yes. The study involved medication, including CONCERTA (OROS methylphenidate hydrochloride).

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies